Longboard Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBPH research report →
Companywww.longboardpharma.com
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies.
- CEO
- Kevin R. Lind
- IPO
- 2021
- Employees
- 50
- HQ
- La Jolla, CA, US
Price Chart
Valuation
- Market Cap
- $2.34B
- P/E
- -25.05
- P/S
- 0.00
- P/B
- 33.31
- EV/EBITDA
- -41.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -106.30%
- ROIC
- -137.11%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-54,422,000 · -26.29%
- EPS
- $-2.39 · 4.78%
- Op Income
- $-56,759,000
- FCF YoY
- -33.64%
Performance & Tape
- 52W High
- $59.98
- 52W Low
- $59.98
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.09
- Avg Volume
- 0
Get TickerSpark's AI analysis on LBPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 2, 24 | Lynch Casey | sell | 22,500 |
| Dec 2, 24 | Lynch Casey | sell | 14,428 |
| Dec 2, 24 | Lynch Casey | sell | 12,500 |
| Dec 2, 24 | Lynch Casey | sell | 12,367 |
| Dec 2, 24 | Le Goff Corinne | sell | 13,397 |
| Dec 2, 24 | Le Goff Corinne | sell | 12,500 |
| Dec 2, 24 | Le Goff Corinne | sell | 12,367 |
| Dec 2, 24 | Le Goff Corinne | sell | 22,500 |
| Dec 2, 24 | SEKHRI PAUL J | sell | 12,500 |
| Dec 2, 24 | SEKHRI PAUL J | sell | 22,500 |
Our LBPH Coverage
We haven't published any research on LBPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LBPH Report →